EMILY EBERT: Open Payments
NPI 1780300848 · CLAY CENTER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 15 payments from 8 companies in 2025. Trend: 2023 $261 · 2024 $814 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Koya Medical, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
| SCPHARMACEUTICALS INC. | 1 | $14 |
Products named: VERQUVO, FARXIGA, Kerendia, CAMZYOS, KOYA MEDICAL, ELIQUIS, REPATHA, LifeVest.
Industry payments across KS — which companies pay providers there.
